ArticleNature communications2026
A membrane-modulated chemoenzymatic dynamic kinetic resolution for the synthesis of chiral phthalidyl esters.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemoenzymatic dynamic kinetic resolution (DKR) offers a powerful bridge between chemocatalysis and biocatalysis for the preparation of chiral molecules. However, its broader application has been limited by the incompatibility between racemization and resolution catalysts, where mutual interference often compromises catalytic activity and/or enantioselectivity. Here, we introduce a membrane-modulated strategy that circumvents the mandatory requirement for strict rate matching, offering a significant conceptual advance in the design of chemoenzymatic DKR systems. By spatially separating racemization and resolution while enabling their collaborative operation within a two-stage, two-step process, this approach dramatically enhances the typically low efficiency of conventional DKR, allowing the efficient synthesis of tetra-substituted 3-hydroxyphthalide esters that are challenging to access by traditional methods, and greatly expanding the scope of chiral phthalide preparation. This membrane-modulated strategy not only streamlines the typically laborious optimization required in conventional DKR for developing an alternative chemoenzymatic DKR approach but also provides a useful platform with the potential for pharmaceutical synthesis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.